Eversana: Alkemy Partners acquisition
Commercial services specialist Eversana has acquired Alkemy Partners, a field learning and development firm. The purchase is intended to expand Eversana’s commercial services platform to help solve a range of challenges for therapies and medical devices, pre-launch and in-market.
Jim Lang, Eversana CEO, said, “Pharmaceutical companies are navigating the realities of a new world; now more than ever, front-line clinical, market access, and field commercial teams need robust training partners offering innovative methods that can be delivered remotely, not traditional strategies. We’re advancing the measures needed to effectively engage all stakeholders in today’s world and leveraging data and analytics to optimize field outreach in real time to ensure appropriate patient utilization.”
